53 , 16101618 (2009) Brtz, H., Bierbaum, G., Reynolds, P
Those characteristics support the use of glucagon in combination with other gastrointestinal hormones that have opposite glucose-lowering effects for the treatment of obesity and T2DM [16]
This reflects several practical and risk-management considerations: Feasibility: 10 mg represents a testable dose that fits typical tablet manufacturing and is easy to dose consistently Precaution: It is substantially lower than the upper range of animal studies when adjusted for expected human bioavailability Tolerability: Community reports suggest 10 mg daily is generally well-tolerated in most users without major adverse effects Observability: At lower doses, any effects (beneficial or adverse) are more likely to be attributable to Dihexa rather than confounding factors Cost-effectiveness: 10 mg balances efficacy expectations with pricing practicality However, "conservative" and "well-tolerated at low doses" does not mean "safe." The absence of clinical trial data means individual responses are unpredictable
Our physicians provide treatment protocols based on patients conditions, objectives, biology, and lifestyle
A: Acute overdose is unlikely to cause serious harm
